Tigermed establishes subsidiary with CSU

Tigermed Consulting, a Chinese contract research organization, has established Hunan Tigermed Xiangya Drug R&D with the local Central South University.

Tigermed Xiangya has three Evaluation Centers: the Drug Clinical Evaluation Center, Pharmaceutical Analysis Center and Drug Pre-clinical Evaluation Center. The DCEC mainly cooperates with the third Xiangya Hospital of the CSU to conduct Phase I clinical trials for new drugs, and pharmacokinetics and bioequiavailability studies in other stages of clinical trials. The PAC is chiefly responsible for the studies related to pharmaceutical analysis. The DPEC is principally in charge of PK screening of compound candidates; PK studies, pharmacodynamics studies, quality specification, and manufacturing process studies during preclinical trials.

Cheng Zeneng, deputy dean of the CSU School of Pharmacy, said: "CSU and its affiliated hospitals are equipped with high technologies and abundant resources, [while] Tigermed has sufficient funds and rich management expertise, so we are quite confident of building up Tigermed Xiangya as a leading Drug Clinical Evaluation Center in China."